Clinical Trial Update: Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing R-CMOP versus R-CHOP as initial therapy for Diffuse Large B-Cell Lymphoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• PREDNISONE (Prednisone)
• R-CHOP
• R-CMOP
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diffuse Large B-Cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING